By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Oncology - Pancreatic Cancer are discussed in a new report. According to news originating from Beijing, People’s Republic of China, by NewsRx correspondents, research stated, “There were many reports suggesting that different kinds of tumors can express B7-H4; however, the prognostic value in cancer was still unclearly. Therefore, we conducted a meta-analysis to investigate the relationship between overexpression of B7-H4 with the prognostic value in pancreatic cancer patients.”
Our news journalists obtained a quote from the research from Peking University, “The Pubmed, Embase, Cochrane Library, Ovid, Web of Science, and Chinese research database (including CBM, CNKI, and WAN FANG) were searched for related literature published until October 12, 2017. The pooled odds ratios (ORs) and/or pooled hazard ratios (HRs) for clinical pathological factors and overall survival (OS) were calculated and analyzed using Stata software. To assess whether an individual study had an impact on the result, sensitivity analysis was performed for all included individual studies using the fixed-effects model. Publication bias was evaluated using Egger’s and Begg’s tests. Data from 6 observational studies including 442 patients were summarized in this meta-analysis, and each study was eligible for inclusion based on included and exclude criteria. The pooled results indicated that the B7-H4 overexpression could predict the presentation of lymph node metastasis (OR=3.94, 95% CI: 1.22-12.66, P=.022), advanced TNM stage (T = the extent of the primary tumor, N = regional lymph nodes, M = distant metastases) (III+IV vs I+II; OR = 7.63, 95% CI: 2.46-23.66, P< .001), and the poor OS (HR = 3.00, 95% CI = 2.20-4.10, P< .001) in PC patients. This study reveals that high expression of B7-H4 is an unfavorable prognostic factor for patients with pancreatic cancer.”
According to the news editors, the research concluded: “These results may guide the clinical management of this patient population.”
For more information on this research see: The prognostic value of B7-H4 in pancreatic cancer Systematic review and meta-analysis. Medicine , 2018;97(12):19-25. Medicine can be contacted at: Lippincott Williams & Wilkins, Two Commerce Sq, 2001 Market St, Philadelphia, PA 19103, USA. (Elsevier - www.elsevier.com; Medicine - http://www.journals.elsevier.com/medicine/)
The news correspondents report that additional information may be obtained from D.R. Xiu, Peking University, Hosp 3, Dept. of Gen Surg, Beijing 100191, People’s Republic of China. Additional authors for this research include L.Y. Tao, C.H. Yuan and X. Chen.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
CITATION: (2018-05-01), Recent Findings from Peking University Has Provided New Information about Pancreatic Cancer (The prognostic value of B7-H4 in pancreatic cancer Systematic review and meta-analysis), Cancer Weekly, 144, ISSN: 1532-4567, BUTTER® ID: 015572790
From the newsletter Cancer Weekly.
https://www.newsrx.com/Butter/#!Search:a=15572790
This is a NewsRx® article created by NewsRx® and posted by NewsRx®. As proof that we are NewsRx® posting NewsRx® content, we have added a link to this steemit page on our main corporate website. The link is at the bottom left under "site links" at https://www.newsrx.com/NewsRxCorp/.
We have been in business for more than 20 years and our full contact information is available on our main corporate website.
We only upvote our posts after at least one other user has upvoted the article to increase the curation awards of upvoters.
NewsRx® offers 195 weekly newsletters providing comprehensive information on all professional topics, ranging from health, pharma and life science to business, tech, energy, law, and finance. Our newsletters report only the most relevant and authoritative information from qualified sources.